About N-SIDE
N-SIDE is a company based in Louvain-la-neuve (Belgium) founded in 2000. N-SIDE has raised $11.79 million across 7 funding rounds from investors including European Union, Gaetan Hannecart and Francois le Hodey. N-SIDE offers products and services including Life Sciences Software and Energy Optimization Solutions. N-SIDE operates in a competitive market with competitors including Korio, Endpoint Clinical, Mosiac InVivo, Nomeco CTSM and Clinapps, among others.
- Headquarter Louvain-la-neuve, Belgium
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.79 M (USD)
in 7 rounds
-
Latest Funding Round
$11.79 M (USD), Series B
Mar 29, 2021
-
Investors
European Union
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of N-SIDE
N-SIDE offers a comprehensive portfolio of products and services, including Life Sciences Software and Energy Optimization Solutions.
Tools to reduce drug waste and optimize clinical manufacturing processes
Solutions for energy forecasting and power matching in markets
People of N-SIDE
Unlock access to complete
Unlock access to complete
Software Development Team
14 people
Leadership Team
13 people
Product Management Team
6 people
Sales and Marketing
6 people
Senior Team
5 people
Data Analysis and Operations Team
3 people
Human Resources and Administration
3 people
Clinical Team
3 people
Unlock access to complete
Funding Insights of N-SIDE
N-SIDE has successfully raised a total of $11.79M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $11.79 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in N-SIDE
N-SIDE has secured backing from 6 investors, including angel and institutional investors. Prominent investors backing the company include European Union, Gaetan Hannecart and Francois le Hodey.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
GH
Gaetan Hannecart |
-
|
Locked | Locked | Locked |
|
FL
Francois le Hodey |
-
|
Locked | Locked | Locked |
Investor details for N-SIDE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by N-SIDE
Investment portfolio details for N-SIDE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - N-SIDE
Detailed financials for N-SIDE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
N-Side Comparisons
Peer comparison for N-SIDE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of N-SIDE
N-SIDE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Korio, Endpoint Clinical, Mosiac InVivo, Nomeco CTSM and Clinapps, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Software for clinical trial supply management and randomization is provided.
|
|
| Locked | Locked | Locked |
Interactive Response Technology systems are provided for clinical trials.
|
|
| Locked | Locked | Locked |
Software solutions for pre-clinical scientific data management in life sciences.
|
|
| Locked | Locked | Locked |
Delivers comprehensive solutions for clinical trial supply management.
|
|
| Locked | Locked | Locked |
Software products and services for the pharmaceutical and biotechnology industries
|
Detailed competitors of N-SIDE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on N-Side
Complete news archive for N-SIDE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about N-SIDE
N-SIDE was founded in 2000 and raised its 1st funding round 16 years after it was founded.
N-SIDE is headquartered in Louvain-la-neuve, Belgium.
Jacques Parlongue is the current CEO of N-SIDE.
N-SIDE is a funded company, having raised a total of $11.79M across 7 funding rounds to date.
N-SIDE was founded in 2000 as a provider of cloud and AI-based analytics focused on supply chain optimization. Services encompass risk management, forecasting, price optimization, prediction, and planning. These tools support operations in the industrial and pharmaceutical sectors. Clients served include Sanofi, ArcelorMittal, and Solvay, with solutions deployed through a digital platform.
N-SIDE's top competitors include Korio, Endpoint Clinical and Clinapps.
N-SIDE offers Life Sciences Software and Energy Optimization Solutions.
N-SIDE has 6 investors. Key investors include European Union, Gaetan Hannecart, Francois le Hodey, Jacques van Rijkervorsel, and Jean Stéphenne.